TAK-733 Uses, Dosage, Side Effects and more
TAK-733 has been used in trials studying the treatment of Advanced Metastatic Melanoma, Advanced Nonhematologic Malignancies, and Advanced Non-hematologic Malignancies.
| Trade Name | TAK-733 |
| Generic | TAK-733 |
| Type | |
| Formula | C17H15F2IN4O4 |
| Weight | Average: 504.2267 Monoisotopic: 504.010604818 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
